C-Peptide Area Under the Curve at Glucagon Stimulation Test Predicts Glucose Improvements by GLP-1 Receptor Analogue: A Retrospective Observational Study-Reference-Cited by-同舟云学术

C-Peptide Area Under the Curve at Glucagon Stimulation Test Predicts Glucose Improvements by GLP-1 Receptor Analogue: A Retrospective Observational Study

Published:2019-02-20 Issue:2 Volume:10 Page:673-681
ISSN:1869-6953
Container-title:Diabetes Therapy
language:en
Short-container-title:Diabetes Ther

Author:

Ohbatake Azusa,Yagi Kunimasa,Karashima Shigehiro,Shima Yuki,Miyamoto Yukiko,Asaka Hiroyuki,Okazaki Satoko,Kometani Mitsuhiro,Kawashiri Masa-aki,Takeda Yoshiyu,Yoneda Takashi,Chujo Daisuke^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://link.springer.com/content/pdf/10.1007/s13300-019-0586-6.pdf

Reference22 articles.

1. DeFronzo RA. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes. 1988;37:667–87.

2. Stumvoll M, Goldstein BJ, van Haeften TW. Type 2 diabetes: principles of pathogenesis and therapy. Lancet. 2005;365:1333–46.

3. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837–53.

4. Funakoshi S, Fujimoto S, Hamasaki A, et al. Analysis of factors influencing pancreatic beta-cell function in Japanese patients with type 2 diabetes: association with body mass index and duration of diabetic exposure. Diabetes Res Clin Pract. 2008;82:353–8.

5. Funakoshi S, Fujimoto S, Hamasaki A, et al. Analysis of factors influencing postprandial C-peptide levels in Japanese patients with type 2 diabetes: comparison with C-peptide levels after glucagon load. J Diabetes Invest. 2012;2:429–34.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of dulaglutide and trelagliptin on beta-cell function in patients with type 2 diabetes: a randomized controlled study: DUET-beta study;Diabetology International;2024-04-03

2. The efficacy and safety of beinaglutide alone or in combination with insulin glargine in Chinese patients with type 2 diabetes mellitus who are inadequately controlled with oral antihyperglycemic therapy: A multicenter, open‐label, randomized trial;Journal of Diabetes;2023-10-20

3. The average 30-minute post-prandial C-peptide predicted diabetic retinopathy progress: a retro-prospective study;BMC Endocrine Disorders;2023-03-16

4. The average 30-minute post-prandial C-peptide predicted diabetic retinopathy progress ： a retro- prospective study;2022-12-14

5. Effectiveness and Safety of Once-Weekly Semaglutide in Japanese Patients with Type 2 Diabetes in Treatment Intensification: A Retrospective Observational Single-Center Study;Diabetes Therapy;2022-08-25